Viewing Study NCT02588105


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-02-25 @ 8:27 PM
Study NCT ID: NCT02588105
Status: COMPLETED
Last Update Posted: 2022-09-19
First Post: 2015-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D6500C00001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View